惯性聚合 高效追踪和阅读你感兴趣的博客、新闻、科技资讯
阅读原文 在惯性聚合中打开

推荐订阅源

量子位
cs.AI updates on arXiv.org
cs.AI updates on arXiv.org
F
Fortinet All Blogs
博客园 - 聂微东
奇客Solidot–传递最新科技情报
奇客Solidot–传递最新科技情报
Hugging Face - Blog
Hugging Face - Blog
V
Visual Studio Blog
小众软件
小众软件
有赞技术团队
有赞技术团队
雷峰网
雷峰网
钛媒体:引领未来商业与生活新知
钛媒体:引领未来商业与生活新知
AWS News Blog
AWS News Blog
C
Cisco Blogs
美团技术团队
T
Threat Research - Cisco Blogs
C
CERT Recently Published Vulnerability Notes
人人都是产品经理
人人都是产品经理
宝玉的分享
宝玉的分享
Threat Intelligence Blog | Flashpoint
Threat Intelligence Blog | Flashpoint
酷 壳 – CoolShell
酷 壳 – CoolShell
Stack Overflow Blog
Stack Overflow Blog
W
WeLiveSecurity
D
DataBreaches.Net
博客园 - 司徒正美
Blog — PlanetScale
Blog — PlanetScale
IT之家
IT之家
云风的 BLOG
云风的 BLOG
Cyber Security Advisories - MS-ISAC
Cyber Security Advisories - MS-ISAC
Simon Willison's Weblog
Simon Willison's Weblog
Google DeepMind News
Google DeepMind News
T
The Blog of Author Tim Ferriss
Know Your Adversary
Know Your Adversary
NISL@THU
NISL@THU
OSCHINA 社区最新新闻
OSCHINA 社区最新新闻
The Cloudflare Blog
Vercel News
Vercel News
月光博客
月光博客
T
Tailwind CSS Blog
H
Help Net Security
aimingoo的专栏
aimingoo的专栏
P
Proofpoint News Feed
Application and Cybersecurity Blog
Application and Cybersecurity Blog
Spread Privacy
Spread Privacy
cs.CL updates on arXiv.org
cs.CL updates on arXiv.org
Cisco Talos Blog
Cisco Talos Blog
Microsoft Security Blog
Microsoft Security Blog
V
V2EX
WordPress大学
WordPress大学
Cyberwarzone
Cyberwarzone
Recent Announcements
Recent Announcements

Forbes - Healthcare

How to Prevent Domestic Violence Deaths UK Smoking Ban Highlights Debate Over The Proper Function Of Government What To Do When Someone You Love Has Cancer Psychedelic Medicine Goes Mainstream: Breakthrough or Bubble? Humana Profits Eclipse $1 Billion As Medicare Costs Ease Slightly What Are Peptides And Why Is Everyone Talking About Them? Tonsillectomy Doesn’t Lead To Illness, But Tonsillitis Just Might Does Retail Pharmacy Have A Tower Records Problem? Precision Radiation Therapy Could Offer New Hope For Hard-To-Treat Cancers Centene’s Obamacare Enrollment Drops By 2 Million After Congress Strips Subsidies RFK Jr.’s Messaging Could Be Impacting Food And Pharmaceutical Choices Over A Million Road Crash Deaths Annually Prompt $350 Million Investment Breast Cancer Screening Tool Avoids Radiation, Compression, Contrast Large Study Finds Benefits Of Doula Care On Postpartum Outcomes TrumpRx Has Signed Deals With Nearly Every Major Drugmaker. Are Prices Actually Falling? America Can’t Lower Healthcare Costs Without A Moonshot Trump’s Orders Elevate The Medical Status Of Psychedelics And Cannabis Mark Cuban’s Cost Plus Drugs, Humana Partner To Take On Employer Drug Costs Cell, Gene And Specialty Drug Costs Intensify For Health Plans U.S. Tennis Participation Continues Growth. Up 54 Percent Since 2019 New AMA Study Finds Burnout Is Decreasing Among Medical Residents And Fellows Daytime Naps May Be A Sign Of Serious Health Problems, Study Reveals New Antibody Drugs Target Disease From Within Concierge Medicine Was Built For The Few. Here’s How To Open It To The Many Burnout in Medicine Is Still Prevalent, With Emergency Medicine Leading Who Is Actually Qualified To Give Advice On Peptides And Who Isn’t What the 49ers Can Teach Leaders About Handling False And Misleading Narratives Do Older Adults Need Routine Colonoscopies Or Low Thyroid Drugs? Your Period, Your Proteins, Your Health Doctors Say Hegseth’s Flu Vaccine Decision Will Weaken Military Readiness Where Bullets Fly, Malaria Kills Using AI To Personalize Healthcare–Without Losing Patient Trust Progress For Preeclampsia Allowing Our Military To Refuse Flu Vaccination Is A Bad Idea. Here’s Why Can Vaccine Development Weather Political Storms? A Virus From Farmed Seafood Is Causing A New Eye Disease In People Elevance Health Profits Eclipse $1.7 Billion Despite Elevated Costs The UK Passes A Lifetime Smoking Ban. Could America Be Next? There's No Such Thing As Brain Honey UnitedHealth Group Profits Eclipse $6 Billion As Medical Costs Ease AI Is Already Here. The Real Risk In Public Health Is Sitting It Out UnitedHealthcare Reduces Need For Prior Approvals For Patients In Rural America Why No Child Should Have To Sacrifice School To Care For Their Family Oscar Health Launches Consumer Marketplace For Insurance Beyond Its Own Calling The Iconic 867-5309 Now Goes To A Cancer Helpline FDA Lists Xanax Recall. Here’s What You Need To Know What Trump’s Ibogaine Executive Order Means For Veterans With PTSD 20 Years Of Priority Review Vouchers, A Tool For Spurring Needed Drugs Rotavirus Is Surging Across The US — Here’s What Parents Need To Know Leadership Dysfunctional In Healthcare: “Split The Baby” Thinking ‘Bedtime Stacking’ Trends On TikTok. Here Are The Risks Why Do Weight Loss Drugs Work For Some And Not Others? It’s In The Genes Hospital Safety: How to Avoid Medical Errors and Protect Yourself Medicare Can Save $4 Billion On Four Cancer Drugs — Can You Guess Which Ones? After 25 Years Of Consumer-Directed Healthcare, What’s Missing? This Sam Altman-Backed $1.8 Billion Startup Bets AI Can Get Drugs Through Clinical Trials Faster RFK Jr. Pushes To Expand Access To Peptides. A Doctor Explains The Risks How The Trump Administration Is Blocking Access To Home Care Genome Sequencing Solves Rare Disease Mysteries Breakthrough HIV Drug Is Out Of Reach For Many Who Need It Most New Drug Protects Against Life-Threatening Pancreatitis This Pill May Help Pancreatic Cancer Patients Live Longer What Should We Do When The Patient Is Racist? Attention Turns To UnitedHealth Earnings For Signs Of Insurer Rebound New Pancreatic Cancer Drug Nearly Doubles Survival. Here’s What Patients Should Know Why Sex Exists A Novel Approach To The Treatment Of Antibiotic Resistant Infections Democrat-Leaning Plan Takes Aim At Health Plans With New Regulations Trump Administration Weighs Default Medicare Advantage Plans For Seniors An AI System Passed Peer Review. The Scientific Community Isn’t Ready Prior Authorization Reform Is Here — And It Could Change How Millions Get Care The More We Add To U.S. Healthcare, The Worse It Gets How Two Sisters Built A $1 Billion HealthTech Unicorn CDC Delays Reporting Of COVID-19 Vaccine Benefits—Here’s What To Know This Startup Wants To Use AI To Help Digitize History Are Nicotine Pouches Like Zyn And VELO Safe To Use? A Doctor Answers America’s Healthcare Innovation Problem GLP-1 Weight Loss Drugs Are Easy To Get—But Are They Safe? Why Cleveland Clinic Chose This AI Startup To Rewire Key Healthcare Operations Upset About The High Price Of Your Hospital Stay? Medicaid Cuts Might Be To Blame Trump’s New Pharmaceutical Tariffs Will Hit Small Drugmakers Hardest A New Way To Target Metastatic Cancer What A Florida Birth Case Reveals About Post-Dobbs Maternal Healthcare 5 Reasons Why the Medicare Program Can’t Go Broke Lowering Healthcare Costs Without A Disastrous Government-Run Model Promising Study Links Coffee Consumption To Reduced Dementia Risk Gene Regulation May Control How Long We Live Health Insurers Get 2.5% Medicare Rate Hike They Feared Would Be Flat Engineered Antibodies Pry Apart The Most Difficult Viruses Centene Latest Health Insurer To Shakeup Management Ranks 1.6 Million Teens Are Vaping. Health Risks Are Worse Than You Think Increasing Burdens Medical Debt And Bankruptcy Are Uniquely American Medicaid Work Requirements Go Live Soon. Here’s How Many Could Lose Coverage What SpaceX’s IPO Means For The Space Economy Thus Far, Most Favored Nation Drug Prices Have Had Little Impact FDA Approves New Oral Weight Loss Pill Foundayo — Here’s What To Know ‘Medicare By Choice’ Plans Could Work, But More Details Needed Criticism of NFL's Rooney Rule Misses How Hiring Actually Works Navigating Health In The Age Of Misinformation NASA Artemis II astronaut health risks explained
AI Risk—Beyond Replacement, Toward Responsibility
Demetri Giannikopoulos · 2026-06-20 · via Forbes - Healthcare
Football coach kneeling with a playboard while discussing strategy with players gathered around during a nighttime practice.

In sports, as in healthcare and customer service, somebody eventually has to explain what happened. Preparation matters.

getty

This week Anthropic disabled access to Fable 5 and Mythos 5 following a government directive citing national security concerns. Predictably, camps developed quickly. Some saw proof that stronger oversight is necessary. Others saw proof that governments cannot be trusted with technologies this important. I suspect both sides missed something. What hit me was how quickly the conversation centered around control and how little time was spent discussing who was expected to absorb the consequences. Everyone says they want guardrails. Everybody says they want responsible AI. But very few people seem particularly interested in what happens when those guardrails create friction, limit access or force uncomfortable tradeoffs.

The situation reminded me of something much smaller. A few months ago, I noticed some meaningful errors in my medical record. The existence of the error itself didn’t particularly surprise me. Healthcare is a human system layered on top of technology systems, and both humans and technology occasionally fail. The information was wrong, multiple people could see that it was wrong, and yet months later it still hasn’t been completely corrected.

What I still haven’t figured out is who actually owns the problem now that it exists. I’ve asked my physical therapist, largely because they’re the person I see most often. No real answers there. I have an appointment with the physician who created the original note next week, and we’ll see where that leads. Beyond that, I simply haven’t had enough time between work and traveling with my family to fully investigate how this process is supposed to work. It now feels less like a documentation error and more like an ownership problem.

We Keep Returning To Replacement

Part of the problem, I think, is that we continue to frame AI primarily through the lens of replacement. Every conversation eventually seems to arrive there. Will radiologists disappear? Will programmers disappear? Will customer service representatives disappear?

During a Senate committee hearing earlier this year, Senator Bernie Moreno walked through examples stretching back nearly a century. Cars were supposed to eliminate jobs. Automation was supposed to eliminate jobs. The internet was supposed to eliminate jobs. I added that Excel spreadsheets were once forecast to eliminate accountants. The predictions never really played out the way people imagined, although work itself changed dramatically.

I don’t say that because I think AI is overhyped. Quite the opposite; some of these capabilities are extraordinary. But I increasingly wonder whether replacement is simply the wrong frame.

Ironically, a surprising amount of the past decade of my career has involved telling people not to use AI. That sounds strange given the organizations I’ve worked with and the roles I’ve held, but many problems don’t actually require probabilistic systems. Sometimes good software is cheaper, easier to govern and easier to explain. It also produces more consistent outcomes. Yet we’re increasingly approaching every problem as though AI must be involved simply because AI is available.

Where Uncertainty Can Exist And Where It Can’t

Consider the process of implementing clinical trials at an investigation site. Protocols change constantly. Inclusion criteria evolve. New exclusions emerge. Amendments arrive. Research teams are asked to identify eligible patients while simultaneously ensuring that the protocol is followed exactly as written. The instinctive answer is often to continuously feed every patient into AI and ask the model whether they qualify.

A more interesting approach, at least to me, is almost boring. When the protocol changes, use AI once. Let it interpret the update, compare it to the previous version, and translate complicated language into a structured ruleset. Have domain experts review that output and make sure it accurately reflects the protocol. Then let conventional software do what conventional software has done extraordinarily well for decades and execute those rules consistently until the next update arrives.

I increasingly suspect we’re allocating AI to the wrong layer.

Some of these systems are incredible. But if the protocol changes once a month, why would I invoke AI millions of times on millions of patients? Use the model ten times a year. Have somebody who actually understands the trial review the output. Then push the rules into software and move on until the next update.
One approach asks experts to inspect the uncertainty once. The other spreads it around and quietly asks everybody downstream to absorb it. Clinicians. Patients. Support teams. Those aren’t the same thing.

Maybe that’s less exciting. It certainly makes for a worse keynote slide. But when you’re the person who has to explain why Patient A got enrolled and Patient B didn’t eighteen months later, boring starts to look pretty attractive. Nobody gets bonus points because the application itself is AI.

The Human May Not Be The Expensive Part

One thing I wonder about is whether AI ends up partially reversing the offshoring story. For decades, organizations pursued labor arbitrage because it made economic sense. The assumption now seems to be that the next step is obvious: eliminate the person entirely. I’m not sure the math works that way.

The standard conversation focuses on how the AI economics themselves are evolving. Much of software spent decades charging for seats and subscriptions. AI introduces a different model. Usage matters. Tokens matter. Compute matters. AI folks use the term inference to describe the process by which models generate response. As subsidies fade and utilization costs become more visible, companies are beginning to discover that inference isn’t free.

But not every interaction carries the same stakes. Password resets and routine requests are one thing. When customers are frustrated, frightened, confused or considering leaving, those become high-risk moments. Those are the moments customers remember. The cost of failure isn’t measured by the first interaction. It’s measured by the second call, the escalation, the customer who quietly disappears or the relationship that never recovers.

AI creates an interesting possibility. Instead of replacing three people with nobody, perhaps one highly skilled person supported by AI can deliver similar economics while staying closer to the customer. Imagine that. Rather than pursuing ever lower labor costs, maybe we can use these systems to build expertise and amplify trust.

And maybe I’m wrong about that. Valuations are myths more than science anyway. I once heard somebody describe them as a pitch deck with a really good presentation attached to it, and there’s probably some truth there. But the assumptions underneath many of these numbers implicitly depend on replacement. At some point the cost has to go somewhere.

This still sounds strange to me every time I say it: in some situations, the human may actually be the most cost-effective inference layer.

Because the cost of intelligence isn’t measured solely in tokens and GPUs. Sometimes it’s the second call. Sometimes it’s the escalation. Sometimes it’s the customer who quietly disappears and never tells you why. Those costs eventually show up somewhere, even if they don’t appear on the cloud bill.

Somebody Eventually Gets The Phone Call

In reality, very little of this looks like the demos. Most of it looks like redesigning workflows and trying to answer questions nobody had to answer before.

Maybe that’s ultimately what made the Anthropic story so interesting to me. Everyone immediately argued about control. Governments. Companies. Models. Access.

I found myself thinking about something much less grand.

Clinical trials, customer service, healthcare: somebody eventually has to explain what happened.

We’re becoming increasingly confident in the technology. I’m less certain we’ve spent the same amount of time deciding who we’re comfortable asking to absorb the consequences when things don’t work exactly as planned.